Skip to main content
Back to Mizuho Capital

Mizuho Capital's Biotechnology Portfolio

Browse 13 Biotechnology companies funded by Mizuho Capital. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
13
Total Funding in Biotechnology
$120.8M

Biotechnology Portfolio Companies (13)

Export
BiotechnologyGeneticsPharmaceutical

A-SEEDS is a biotech company that researches and develops regenerative medicines, especially for cancer patients.

Matsumoto, Japan
July 2025
$15.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife Science

Modalis is a biotech company that develops therapeutics using CRISPR based technology.

Tokyo, Japan
June 2025
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsTherapeutics

Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.

Tokyo, Japan
June 2026
$32.8M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyManufacturingTherapeutics

Cyto-Facto is a biotechnology company that develops and manufactures CAR-T cell therapies and mesenchymal stem cell products.

Minamimachi, Japan
April 2024
$7.6M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyClinical TrialsMedicalPharmaceutical

Alivexis is a biotechnology company that engages in the research and development of custom medicine for the pharmaceutical industry.

Minato, Japan
March 2022
$20.4M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyMedical DevicemHealth

FunPep is a biotechnology firm that develops functional cosmetics, medical supplies, and pharmaceutical drugs for people's well-being.

Tokyo, Japan
February 2026
$5.5M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

Alternative MedicineBiotechnologyPharmaceuticalProduct Research

KAICO is a biotechnology company that provides hard-expressing proteins to develop drugs with a silkworm-baculovirus expression system.

Nishiku, Japan
April 2025
$3.8M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareProduct Research

Luxana Biotech is established to contribute to medical treatment for suffering patients, .

Osaka, Japan
September 2024
$1.7M
Series C

Founder Contacts

30,000+ verified contacts

AgricultureBiotechnologyEnvironmental ConsultingLife Science

GRA&GREEN is a biotechnology company that provides seed development for agriculture, forestry, and raw materials for food processing.

Nagoya, Japan
June 2024
$4.1M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyClinical TrialsMedicalTherapeutics

Metagen Therapeutics is a drug discovery and medical business company that utilizes microbiome science.

Tsuruoka, Japan
February 2026
$7.6M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyClinical TrialsHealth CareWellness

CellAxia is a biotechnology firm that researches, develops, and markets pharmaceuticals and regenerative medicine products.

Tokyo, Japan
September 2020
$6.6M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

Cellspect is a biotechnology business that creates biomarker-sensing technology for the transition from clinical to health tech markets.

Morioka, Japan
November 2019
$6.9M
Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical DeviceQuantum Computing

Application of quantum mechanics to the development of innovative single-molecule DNA sequencers

Menlo Park, United States
November 2018
$8.9M
Series C

Founder Contacts

30,000+ verified contacts

Explore Mizuho Capital's Full Portfolio

View all companies funded by Mizuho Capital across every industry and funding stage.

View Full Mizuho Capital Portfolio